首页> 美国卫生研究院文献>Journal of General and Family Medicine >A case of successful concomitant administration of warfarin and uracil‐tegafur/leucovorin achieved by self‐measurement of INR
【2h】

A case of successful concomitant administration of warfarin and uracil‐tegafur/leucovorin achieved by self‐measurement of INR

机译:通过INR自测成功合并华法林和尿嘧啶-替加氟/亚叶酸治疗的案例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A woman in her seventies who was started on warfarin after heart valve replacement began outpatient adjuvant chemotherapy with tegafur‐uracil/leucovorin for rectal cancer. The patient performed weekly INR self‐measurements at a health insurance pharmacy between outpatient visits. Results recorded in her personal medicine notebook were shared between her physician, a hospital pharmacist, and a pharmacy pharmacist. When INR values were outside the therapeutic target range, doses were altered according to the physician's instruction. Our approach enables the fine adjustment of warfarin doses according to changes in INR and contributes to the maintenance of the therapeutic target range and safe and appropriate outpatient chemotherapy.
机译:一名七十岁的妇女在心脏瓣膜置换术后开始使用华法林,开始用替加氟尿嘧啶/亚叶酸钙进行门诊辅助化疗以治疗直肠癌。患者在门诊就诊之间在健康保险药房每周进行INR自我测量。她的个人药品笔记本中记录的结果由她的医师,医院药师和药房药师共享。当INR值超出治疗目标范围时,根据医生的指示更改剂量。我们的方法能够根据INR的变化对华法林剂量进行精细调整,并有助于维持治疗目标范围以及安全,适当的门诊化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号